Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceu…
$0.64+3.42%
报价 2026-11-06
市值
$29.3M
EV
$102.8M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -86.3%
$0.62$4.68
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RPIDRapid Micro Biosystems, Inc. | $29.3M | +3.4% | +17.6% | 12.4% | – | – | – | |
| RCELAVITA Medical, Inc. | $412.1M | +5.8% | – | 81.6% | – | – | – | |
| APYXApyx Medical Corporation | $123.4M | -4.2% | +14.2% | 34.5% | – | – | – | |
| OWLTOwlet, Inc. | $121.9M | -1.7% | +15.4% | 54.7% | – | – | – | |
| VANIVivani Medical, Inc. | $96.5M | +2.9% | -100.0% | 0% | – | – | – | |
| SERASera Prognostics, Inc. | $84.3M | +5.3% | +300.0% | -191.2% | – | – | – | |
| LUCDLucid Diagnostics Inc. | $76M | +2.0% | +60.9% | -25.8% | – | – | – | |
| LNSRLENSAR, Inc. | $67M | -0.9% | -3.3% | 48% | 6.7x | 2.6x | – | |
| CGTXCognition Therapeutics, Inc. | $65.3M | +8.1% | +14.4% | 0% | – | – | – | |
| 同行中位数 | – | – | +14.4% | 17.2% | 6.7x | 2.6x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。